ClinicalTrials.gg
Drug

Ferric carboxymaltose clinical trials

Also written Injectafer and VIT-45.

studies test it
158
open now
24
in phase 3
49
first study started
2005

How each study uses ferric carboxymaltose is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the ferric carboxymaltose studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
25 Jul 2013 · INJECTAFER · NDA 203565 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Ferric carboxymaltose
73
Ferinject
66
Ferric Carboxymaltose (FCM)
21
Iron Carboxymaltose
8
Ferinject ® (Ferric carboxymaltose)
6

Brand

Injectafer
19

Development codes

VIT-45
3

Studies by the year they started

158 studies that test it; most in 2017 (18)

Studies that test ferric carboxymaltose, by start year
YearStudies
20055
20064
20073
20086
20098
20107
20115
20124
20138
20149
20159
20166
201718
20185
201910
20208
20218
20227
20237
20246
20257
20268

By phase

A phase 1/2 study counts in both.

Phase 1
7
Phase 2
21
Phase 3
49
Phase 4
66
No phase
18

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 46 · Other 112

American Regent, Inc. (28) · Vifor Pharma (12) · University of Zurich (5) · Sichuan Huiyu Pharmaceutical Co., Ltd (3) · University of Oxford (3) · Konkuk University Medical Center (3) · Vifor (International) Inc. (2) · National Cancer Center, Korea (2)

Often tested with

Tested in the same studies.

Ferrous sulfate (5) · Iron sucrose (4) · Iron isomaltoside 1000 (3) · Ferrous fumarate (3) · Sodium Chloride (3) · Folic Acid (2) · Erythropoietin (2) · Ferroglycine sulfate (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Ferric carboxymaltose is the comparator. A study of two new drugs counts under both.

  • 1Ferric bepectate · AFT Pharmaceuticals, Ltd. · next primary completion Jun 2028
Reaching primary completion within a year · 6, 2 in phase 3

Studies that test ferric carboxymaltose, phase 3 first.

Studies

Open first, then newest update. How each study uses ferric carboxymaltose is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 158

See all 158 studies that test ferric carboxymaltose →

Given beside what is tested · 4 — ferric carboxymaltose is usual care or a partner of the new treatment
As the comparator · 10 — what is tested is compared with ferric carboxymaltose

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call ferric carboxymaltose · ClinicalTrials.gg INT005146

  • MeSH (NLM) C522335ferric carboxymaltoseConfirmed NLM, Wikidata
  • UNII (FDA) 6897GXD6OEFERRIC CARBOXYMALTOSEConfirmed FDA, NLM, Wikidata
  • RxNorm 1433693Confirmed FDA, Wikidata
  • Wikidata Q20817270ferric carboxymaltoseConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C166915Ferric CarboxymaltoseOne source FDA
  • DrugBank DB08917One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.